Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A
- Status
- UNKNOWN
- Phase
- PHASE2
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Compare the Bioequivalence and Safety of JHL1101 and Rituximab in CD20 Positive B Cell Lymphoma Patients
- Status
- TERMINATED
- Phase
- PHASE1
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Personalized Therapies in Inflammatory Complex Disease
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab + Immunotherapy in Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE2
Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia
- Status
- COMPLETED
- Phase
- PHASE2